Literature DB >> 22704695

Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia.

Hyacinth I Hyacinth1, Beatrice E Gee, Thomas V Adamkiewicz, Robert J Adams, Abdullah Kutlar, Jonathan K Stiles, Jacqueline M Hibbert.   

Abstract

Sickle cell anemia (SCA) associated cerebrovascular disease includes vascular remodeling, abnormal cerebral blood flow (CBF) and infarction. We studied the relationships between plasma brain derived neurotropic factor (BDNF), platelet derived growth factors (PDGF-AA and -AB/BB) and high trans-cranial Doppler (TCD) velocity, an indication of CBF velocity. Baseline plasma samples from 39 children (19 SCA with abnormal/high TCD [SATCD], 13 SCA with normal TCD [SNTCD] and 7 healthy non-SCA), were assayed for BDNF, PDGF-AA and -AB/BB plus 11 other cytokines. The sensitivity, specificity and usefulness of these biomarkers for stroke prediction was investigated. All subject groups were of similar age and gender distribution. Mean BDNF was significantly higher among SATCD than SNTCD (p=0.004) as was mean PDGF-AA (p=0.001). Similarly, mean PDGF-AA was higher among SCA subjects who developed stroke than those who did not (p=0.012). Elevated BDNF and PDGF-AA were good predictors of the presence of abnormally high CBF velocity and were both associated with severity of anemia. Elevated PDGF-AA predicted risk for stroke development. Stroke incidence and high TCD velocity were associated with elevated BDNF and PDGF-AA. These findings suggest a role for BDNF and PDGF-AA in the patho-physiological mechanism of cerebrovascular disease in SCA.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704695      PMCID: PMC3429653          DOI: 10.1016/j.cyto.2012.05.017

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  43 in total

Review 1.  Transcranial Doppler ultrasonography monitoring of cerebral hemodynamics during performance of cognitive tasks: a review.

Authors:  N Stroobant; G Vingerhoets
Journal:  Neuropsychol Rev       Date:  2000-12       Impact factor: 7.444

2.  The platelet-derived growth factor isomers, PDGF-AA, PDGF-AB and PDGF-BB, induce contraction of vascular smooth muscle cells by different intracellular mechanisms.

Authors:  A Sachinidis; R Locher; J Hoppe; W Vetter
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

3.  Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease.

Authors:  J Schatz; R T Brown; J M Pascual; L Hsu; M R DeBaun
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

4.  Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat.

Authors:  I Ferrer; J Krupinski; E Goutan; E Martí; S Ambrosio; E Arenas
Journal:  Acta Neuropathol       Date:  2001-03       Impact factor: 17.088

5.  Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family.

Authors:  A Hohn; J Leibrock; K Bailey; Y A Barde
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

6.  Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.

Authors:  W R Schäbitz; C Sommer; W Zoder; M Kiessling; M Schwaninger; S Schwab
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

7.  Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter.

Authors:  L M Khachigian; K R Anderson; N J Halnon; M A Gimbrone; N Resnick; T Collins
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-10       Impact factor: 8.311

8.  Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain.

Authors:  P Ernfors; C F Ibáñez; T Ebendal; L Olson; H Persson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures.

Authors:  Roberta Bovolenta; Silvia Zucchini; Beatrice Paradiso; Donata Rodi; Flavia Merigo; Graciela Navarro Mora; Francesco Osculati; Elena Berto; Peggy Marconi; Andrea Marzola; Paolo F Fabene; Michele Simonato
Journal:  J Neuroinflammation       Date:  2010-11-18       Impact factor: 8.322

10.  Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease.

Authors:  Xiaomei Niu; Mehdi Nouraie; Andrew Campbell; Sohail Rana; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; N Scott Reading; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more
  14 in total

1.  Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk.

Authors:  Hyacinth I Hyacinth; Robert J Adams; Jenifer H Voeks; Jacqueline M Hibbert; Beatrice E Gee
Journal:  Am J Hematol       Date:  2013-11-28       Impact factor: 10.047

Review 2.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

Review 3.  Chronic organ failure in adult sickle cell disease.

Authors:  Elliott Vichinsky
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Brain-derived neurotrophic factor levels in pediatric sickle cell disease.

Authors:  Eboni I Lance; Emily Barron-Casella; Allen D Everett; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2019-11-17       Impact factor: 3.167

Review 5.  Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics.

Authors:  Junaid Ansari; Felicity N E Gavins
Journal:  Am J Pathol       Date:  2019-04       Impact factor: 4.307

6.  Combination of early and delayed ischemic postconditioning enhances brain-derived neurotrophic factor production by upregulating the ERK-CREB pathway in rats with focal ischemia.

Authors:  Hui Wu; Shao-Feng Yang; Jiong Dai; Yong-Ming Qiu; Yi-Feng Miao; Xiao-Hua Zhang
Journal:  Mol Med Rep       Date:  2015-09-15       Impact factor: 2.952

Review 7.  Morphine for the treatment of pain in sickle cell disease.

Authors:  Mihir Gupta; Lilian Msambichaka; Samir K Ballas; Kalpna Gupta
Journal:  ScientificWorldJournal       Date:  2015-01-12

8.  Interleukin-10 haplotypes are not associated with acute cerebral ischemia or high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia.

Authors:  André Rolim Belisário; Rahyssa Rodrigues Sales; Nayara Evelin Toledo; Cibele Velloso-Rodrigues; Célia Maria Silva; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2017-02-21

Review 9.  Biologic complexity in sickle cell disease: implications for developing targeted therapeutics.

Authors:  Beatrice E Gee
Journal:  ScientificWorldJournal       Date:  2013-03-25

10.  Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.

Authors:  Hyacinth I Hyacinth; Robert J Adams; Charles S Greenberg; Jenifer H Voeks; Allyson Hill; Jacqueline M Hibbert; Beatrice E Gee
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.